CHIT1 and cancer: Chitotriosidase and neopterin have been previously evaluated together as biomarkers of macrophage activation in infectious diseases such as brucellosis [23], ankylosing spondylitis [24], microvascular complications of type I diabetes [6], and even lung [25], breast [17], and prostate [17] cancer.